Peroxisomes in human health and disease: Metabolic pathways, metabolite transport, interplay with other organelles and signal transduction

Subcellular Biochemistry

Volumn 69, Issue , 2013, Pages 23-44

  Wanders, Ronald J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Fatty acids; Mitochondria; Peroxisomes; Signal transduction; Zellweger syndrome

Indexed keywords

ANIMAL; DISORDERS OF PEROXISOMAL FUNCTIONS; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMAN; METABOLISM; MITOCHONDRION; PEROXISOME; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMANS; MITOCHONDRIA; PEROXISOMAL DISORDERS; PEROXISOMES; SIGNAL TRANSDUCTION;

EID: 84885365145     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-6889-5_2     Document Type: Article

References (60)

1. Baumgart E, Fahimi HD, Stich A, Volkl A (1996) L-lactate dehydrogenase A4- and A3B isoforms are bona fide peroxisomal enzymes in rat liver. Evidence for involvement in intraperoxisomal NADH reoxidation. J Biol Chem 271:3846-3855
2. Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235-253
3. Bradshaw HB, Walker JM (2005) The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol 144:459-465
4. Brites P,Waterham HR, Wanders RJA (2004) Functions and biosynthesis of plasmalogens in health and disease. Biochim Biophys Acta 1636:219-231
5. Brown FR, McAdams AJ, Cummins JW, Konkol R, Singh I, Moser AB, Moser HW (1982) Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J 151: 344-351
6. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrere F, Blanche S, Audit M, Payen E, Leboulch P, l'Homme B, Bougneres P, Von KC, Fischer A, Cavazzana-Calvo M, Aubourg P (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326:818-823
7. Cooper TG, Beevers H (1969) Beta oxidation in glyoxysomes from castor bean endosperm. J Biol Chem 244:3514-3520
8. de Waart DR, Koomen GC, Wanders RJA (1994) Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2. Biochim Biophys Acta 1226:44-48
9. del Río LA (2011) Peroxisomes as a cellular source of reactive nitrogen species signal molecules. Arch Biochem Biophys 506:1-11
10. del Río LA, Corpas FJ, Sandalio LM, Palma JM, Gomez M, Barroso JB (2002) Reactive oxygen species, antioxidant systems and nitric oxide in peroxisomes. J Exp Bot 53:1255-1272
11. del Río LA, Sandalio LM, Corpas FJ, Palma JM, Barroso JB (2006) Reactive oxygen species and reactive nitrogen species in peroxisomes. Production, scavenging, and role in cell signaling. Plant Physiol 141:330-335
12. Diczfalusy U, Kase BF, Alexson SE, Bjorkhem I (1991) Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans. J Clin Invest 88:978-984
13. Diczfalusy U, Vesterqvist O, Kase BF, Lund E, Alexson SE (1993) Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome. J Lipid Res 34:1107-1113
14. Ebberink MS, Koster J, Visser G, van Spronsen FJ, Stolte-Dijkstra I, Smit GPA, Fock JM, Kemp S, Wanders RJA, Waterham HR (2012) A novel human defect of peroxisome division due to a homozygous non-sense mutation in the PEX11 beta gene. J Med Genet 49:307-313
15. Fransen M, Nordgren M, Wang B, Apanasets O (2012) Role of peroxisomes in ROS/RNSmetabolism: Implications for human disease. Biochim Biophys Acta 1822:1363-1373
16. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, ValsamisMP,Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM (1973) Peroxisomal and mitochondrial defects in the cerebro-hepatorenal syndrome. Science 182:62-64
17. Gorgas K, Teigler A, Komljenovic D, Just WW (2006) The ether lipid-deficient mouse: tracking down plasmalogen functions. Biochim Biophys Acta 1763:1511-1526
18. Hertz R, Magenheim J, Berman I, Bar-Tana J (1998) Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392:512-516
19. Heymans HSA, Schutgens RBH, Tan R, van den Bosch H, Borst P (1983) Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature 306:69-70
20. Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B, Jones SA (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17:1581-1591
21. Houten SM, Denis S, Argmann CA, Jia Y, Ferdinandusse S, Reddy JK, Wanders RJA (2012) Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids. J Lipid Res 53:1296-1303
22. Hunt MC, Siponen MI, Alexson SE (2012) The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim Biophys Acta 1822:1397-1410
23. Inagaki T, ChoiM,Moschetta A, Peng L, Cummins CL,McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217-225
24. Jedlitschky G, Mayatepek E, Keppler D (1993) Peroxisomal leukotriene degradation: biochemical and clinical implications. Adv Enzyme Regul 33:181-194
25. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O (2005) Fatty acid regulation of hepatic gene transcription. J Nutr 135:2503-2506
26. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-4323
27. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, Yasukawa M (2006) Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347:827-832
28. Kruska N, Reiser G (2011) Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2?? signaling through activation of free fatty acid receptor GPR40. Neurobiol Dis 43:465-472
29. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M (2007) Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282:26687-26695
30. Lazarow PB, De Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73:2043-2046
31. Lu J, Caplan MS, Li D, Jilling T (2008) Polyunsaturated fatty acids block platelet-activating factorinduced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294:G1181-G1190
32. Mayatepek E, Flock B (1999) Increased urinary excretion of LTB4 and omega-carboxy-LTB4 in patients with Zellweger syndrome. Clin Chim Acta 282:151-155
33. Mayatepek E, Ferdinandusse S, Meissner T, Wanders RJA (2004) Analysis of cysteinyl leukotrienes and their metabolites in bile of patients with peroxisomal or mitochondrial betaoxidation defects. Clin Chim Acta 345:89-92
34. O'Byrne J, Hunt MC, Rai DK, Saeki M, Alexson SE (2003) The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine. J Biol Chem 278:34237-34244
35. Oh DY, Yoon JM, Moon MJ, Hwang JI, Choe H, Lee JY, Kim JI, Kim S, Rhim H, O'Dell DK, Walker JM, Na HS, Lee MG, Kwon HB, Kim K, Seong JY (2008) Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. J Biol Chem 283:21054-21064
36. Pellicoro A, van den Heuvel FA, Geuken M, Moshage H, Jansen PL, Faber KN (2007) Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport. Hepatology 45:340-348
37. Perichon R, Moser AB, Wallace WC, Cunningham SC, Roth GS, Moser HW (1998) Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. Biochem Biophys Res Commun 248:57-61
38. Reilly SJ, O'Shea EM, Andersson U, O'Byrne J, Alexson SE, Hunt MC (2007) A peroxisomal acyltransferase in mouse identifies a novel pathway for taurine conjugation of fatty acids. FASEB J 21:99-107
39. Reiser G, Schonfeld P, Kahlert S (2006) Mechanism of toxicity of the branched-chain fatty acid phytanic acid, a marker of Refsum disease, in astrocytes involves mitochondrial impairment. Int J Dev Neurosci 24:113-122
40. Rodemer C, Thai TP, Brugger B, Kaercher T, Werner H, Nave KA, Wieland F, Gorgas K, Just WW (2003) Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum Mol Genet 12:1881-1895
41. Ronicke S, Kruska N, Kahlert S, Reiser G (2009) The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes. Neurobiol Dis 36:401-410
42. Roy M-O, Hannedouche S (2007) Ligand for G-protein coupled receptor GPR72 and uses thereof, Canadian Patent Application, pp 1-99
43. Saghatelian A, McKinney MK, Bandell M, Patapoutian A, Cravatt BF (2006) A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry 45:9007-9015
44. Salido E, Pey AL, Rodriguez R, Lorenzo V (2012) Primary hyperoxalurias: disorders of glyoxylate detoxification. Biochim Biophys Acta 1822:1453-1464
45. Savary S, Trompier D, Andreoletti P, Le BF, Demarquoy J, Lizard G (2012) Fatty acids - induced lipotoxicity and inflammation. Curr Drug Metab 13:1358-1370
46. Spector AA, Fang X, Snyder GD, Weintraub NL (2004) Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43:55-90
47. Stables MJ, Gilroy DW (2011) Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res 50:35-51
48. Stroeve JH, Brufau G, Stellaard F, Gonzalez FJ, Staels B, Kuipers F (2010) Intestinal FXRmediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest 90:1457-1467
49. Tan B, O'Dell DK, Yu YW, Monn MF, Hughes HV, Burstein S, Walker JM (2010) Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J Lipid Res 51:112-119
50. Tsikas D, Schwedhelm E, Fauler J, Gutzki FM, Mayatepek E, Frolich JC (1998) Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 716:7-17
51. van Roermund CWT, Elgersma Y, Singh N, Wanders RJA, Tabak HF (1995) The membrane of peroxisomes in Saccharomyces cerevisiae is impermeable to NAD(H) and acetyl-CoA under in vivo conditions. EMBO J 14:3480-3486
52. van Roermund CWT, Hettema EH, Kal AJ, van den Berg M, Tabak HF, Wanders RJA (1998) Peroxisomal beta-oxidation of polyunsaturated fatty acids in Saccharomyces cerevisiae: isocitrate dehydrogenase provides NADPH for reduction of double bonds at even positions. EMBO J 17:677-687
53. Van Veldhoven PP (2010) Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 51:2863-2895
54. Vanhove GF, Van Veldhoven PP, Fransen M, Denis S, Eyssen HJ, Wanders RJA, Mannaerts GP (1993) The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidney. J Biol Chem 268:10335-10344
55. Verhoeven NM, Roe DS, Kok RM, Wanders RJA, Jakobs C, Roe C (1998) Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts. J Lipid Res 39:66-74
56. Wanders RJA, Brites P (2010) Biosynthesis of ether-phospholipids including plasmalogens, peroxisomes and human disease: new insights into an old problem. Clin Lipidol 5:379-386
57. Wanders RJA, Waterham HR (2006) Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 75:295-332
58. Wanders RJA, Komen JC, Ferdinandusse S (2011) Phytanic acid metabolism in health and disease. Biochim Biophys Acta 1811:498-507
59. Waterham HR, Koster J, van Roermund CWT, Mooyer PAW,Wanders RJA, Leonard JV (2007) A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 356:1736-1741
60. Yoshikawa T, Shimano H, Yahagi N, Ide T, Amemiya-Kudo M,Matsuzaka T, Nakakuki M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Takahashi A, Sone H, Osuga JJ, Gotoda T, Ishibashi S, Yamada N (2002) Polyunsaturated fatty acids suppress sterol regulatory elementbinding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277:1705-1711